Dividend Aristocrats close to 52-Week High by Dividend Yield - Stock, Capital, Investment. Here is a current sheet of stocks that have raised their dividends for more than 25 consecutive years and being part of the Dividend Aristocrats index, created by Standard & Poor’s. The index summarizes 42 stocks of which 11 are close to their one-year-highs (up to 5 percent below high).
Here are the 3 top dividend stocks by dividend yield:
The total debt representing 29.56 percent of the company’s assets and the total debt in relation to the equity amounts to 94.76 percent. Due to the financial situation, the return on equity amounts to 9.31 percent. Finally, earnings per share amounts to $3.72 of which $2.38 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 15.65, Price/Sales 1.27 and Price/Book ratio 1.40. Dividend Yield: 4.15 percent. The beta ratio is 0.26.
 |
| Long-Term Stock Chart Of Consolidated Edison, Inc. (Click to enlarge) |
Kimberly Clark (NYSE:KMB) has a market capitalization of $27.63 billion. The company employs 57,000 people, generates revenues of $19,746.00 million and has a net income of $1,762.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3,611.00 million. Because of these figures, the EBITDA margin is 18.29 percent (operating margin 14.04 percent and the net profit margin finally 8.92 percent).
The total debt representing 32.78 percent of the company’s assets and the total debt in relation to the equity amounts to 110.04 percent. Due to the financial situation, the return on equity amounts to 32.55 percent. Finally, earnings per share amounts to $4.18 of which $2.64 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 16.76, Price/Sales 1.40 and Price/Book ratio 4.82. Dividend Yield: 4.00 percent. The beta ratio is 0.34.
 |
| Long-Term Stock Chart Of Kimberly Clark Corp (Click to enlarge) |
Abbott Laboratories (NYSE:ABT) has a market capitalization of $83.37 billion. The company employs 90,000 people, generates revenues of $35,166.72 million and has a net income of $4,626.17 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,711.89 million. Because of these figures, the EBITDA margin is 24.77 percent (operating margin 17.31 percent and the net profit margin finally 13.15 percent).
The total debt representing 31.82 percent of the company’s assets and the total debt in relation to the equity amounts to 84.50 percent. Due to the financial situation, the return on equity amounts to 20.45 percent. Finally, earnings per share amounts to $2.90 of which $1.76 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 18.44, Price/Sales 2.37 and Price/Book ratio 3.69. Dividend Yield: 3.59 percent. The beta ratio is 0.31.
 |
| Long-Term Stock Chart Of Abbott Laboratories (Click to enlarge) |
Here is the full table with some fundamentals (TTM):
 |
| 11 Dividend Aristocrats Close To 52-Week Highs (Click to enlarge) |
Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 18.0 while the forward price to earnings ratio is 15.4. The dividend yield has a value of 2.5 percent. Price to book ratio is 4.3 and price to sales ratio 1.8. The operating margin amounts to 15.5 percent.
Related stock ticker symbols:
ED, KMB, ABT, MCD, WMT, MKC, HRL, SHW, GWW, ECL, BF-B
Selected Articles:
